Ohcanbohtosat - L. Puig

Aiddostahte ozu
  1. 1
    Eight years experience using the inferior epigastric artery for myocardial revascularization

    Eight years experience using the inferior epigastric artery for myocardial revascularization Dahkki L. Puig

    Almmustuhtton 1997
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis

    Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis Dahkki L. Puig

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic

    Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic Dahkki Tiago Torres, L. Puig

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease

    Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic Disease Dahkki Helena Iznardo, L. Puig

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Dual inhibition of IL-17A and IL-17F in psoriatic disease

    Dual inhibition of IL-17A and IL-17F in psoriatic disease Dahkki Helena Iznardo, L. Puig

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Pathophysiology of Generalized Pustular Psoriasis

    Pathophysiology of Generalized Pustular Psoriasis Dahkki Slaheddine Marrakchi, L. Puig

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications

    IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications Dahkki Helena Iznardo, L. Puig

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Tyk2 Targeting in Immune-Mediated Inflammatory Diseases

    Tyk2 Targeting in Immune-Mediated Inflammatory Diseases Dahkki Lluís Rusiñol, L. Puig

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis

    Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis Dahkki Lluís Rusiñol, L. Puig

    Almmustuhtton 2024
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies

    Pathogenic Role of IL-17 and Therapeutic Targeting of IL-17F in Psoriatic Arthritis and Spondyloarthropathies Dahkki Guillermo Sánchez-Rodríguez, L. Puig

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Genetic and Epigenetic Mechanisms of Psoriasis

    Genetic and Epigenetic Mechanisms of Psoriasis Dahkki Laura Mateu Arrom, L. Puig

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Expression and function of APP and its metabolites outside the central nervous system

    Expression and function of APP and its metabolites outside the central nervous system Dahkki Kendra L. Puig, Colin K. Combs

    Almmustuhtton 2012
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Treatment Options and Goals for Patients with Generalized Pustular Psoriasis

    Treatment Options and Goals for Patients with Generalized Pustular Psoriasis Dahkki James G. Krueger, L. Puig, Diamant Thaçi

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Deucravacitinib for the Treatment of Psoriatic Disease

    Deucravacitinib for the Treatment of Psoriatic Disease Dahkki Ana Maria Lé, L. Puig, Tiago Torres

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    New and Emerging Biological and Oral/Topical Small-Molecule Treatments for Psoriasis

    New and Emerging Biological and Oral/Topical Small-Molecule Treatments for Psoriasis Dahkki Elena Carmona‐Rocha, Lluís Rusiñol, L. Puig

    Almmustuhtton 2024
    Viečča ollesdeavstta
    Pré-impressão
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    New and Emerging Oral/Topical Small-Molecule Treatments for Psoriasis

    New and Emerging Oral/Topical Small-Molecule Treatments for Psoriasis Dahkki Elena Carmona‐Rocha, Lluís Rusiñol, L. Puig

    Almmustuhtton 2024
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology

    Exploring the Therapeutic Landscape: A Narrative Review on Topical and Oral Phosphodiesterase-4 Inhibitors in Dermatology Dahkki Elena Carmona‐Rocha, Lluís Rusiñol, L. Puig

    Almmustuhtton 2025
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Pomegranate Polyphenols and Extract Inhibit Nuclear Factor of Activated T-Cell Activity and Microglial Activation In Vitro and in a Transgenic Mouse Model of Alzheimer Disease

    Pomegranate Polyphenols and Extract Inhibit Nuclear Factor of Activated T-Cell Activity and Microglial Activation In Vitro and in a Transgenic Mouse Model of Alzheimer Disease Dahkki Lalida Rojanathammanee, Kendra L. Puig, Colin K. Combs

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis

    Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis Dahkki Helena Iznardo, Esther Roé, E. Serra‐Baldrich, L. Puig

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Clear or almost clear skin improves the quality of life in patients with moderate‐to‐severe psoriasis: a systematic review and meta‐analysis

    Clear or almost clear skin improves the quality of life in patients with moderate‐to‐severe psoriasis: a systematic review and meta‐analysis Dahkki L. Puig, Howard Thom, Patrick Mollon, Hongqing Tian, G.S. Ramakrishna

    Almmustuhtton 2016
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: